A Novel Gene Therapy Using CRIPR/Cas9 Mediated Cellular Reprogramming
CSEF · 2017 Biochemistry/ Molecular Biology
Overview
Objectives/Goals Gene therapy shows great promise in treating many human diseases. However, one major drawback of the current technology is that it can only be directed to a particular mutation or a single gene at best. Retinitis pigmentosa (RP) is a major cause of blindness characterized by retinal rod photoreceptors degeneration. It can be caused by numerous mutations in many genes. My goal is to restore tissue architecture and visual function by switching a mutation-venerable/sensitive rod cell type to a mutation-insensitive/resistant cone cell type. This is accomplished by inactivating Nrl, a key gene controlling binary switch between rods and cones. Methods/Materials I designed AAV constructs to introduce CRISPR/Cas9 system into rod photoreceptor cells in the eye. I used PCR and immunohistochemistry to assess efficiency of gene editing. Results We show an increase in cone like cells with concomitant preservation of both cone and rod photoreceptors and visual function in a RP models by inactivation of NRL gene. Conclusions/Discussion Our approach shows promise of cellular reprogramming in preventing retinal degeneration and preserving vision, and points to a novel approach in treating human diseases in a gene and mutation independent manner.
Summary statement
I used CRISPR/Cas9 mediated gene therapy to inactivate NRL gene in rod photoreceptors in the eye and achieved prevention of retinal degeneration and restoration of visual function.
Help received
I designed and performed the in vitro gene editing assay, and helped with immunohistochemistry and with animal experiment design. I received guidance in project design from Dr. Xin Fu at UC San Diego.
Competition history
- CSEF 2017
Resources
Related projects
CSEF · 2017
Identification of Mutations in a Novel Gene Responsible for Blindness
ISEF · 2016
“Let There Be Light!” rAAV Mediated Delivery of shRNA in a Canine Model of Autosomal-dominant Retinitis pigmentosa
CSEF · 2018
Enhancing Gene Therapy through Targeted Delivery of CRIPSR/Cas9 in a Novel, Inexpensive Lipid Nanoparticle
ISEF · 2025
A Newly Identified Chromatin Remodeling Pathway in the Lens Enables a Proof-of-Concept Gene Therapy for Posterior Capsule Opacification
CSEF · 2019
Generation of MPS IIIA Induced Pluripotent Stem Cells for Correction Using CRISPR Cas9
ISEF · 2021
X Linked Retinitis Pigmentosa and Age-related Macular Treatment by Induced Pluripotent Stem Cells AMD / XLRP >> IPSC
ISEF · 2026
Uncovering a New Avenue to Fight Retinal Diseases: Identifying Retinal Ganglion Cells as a Novel Signaling Pathway Through Fixational Eye Movements With Discovery of the ZNF385D Biomarker Group for AKB-9778 Therapeutic Intervention
ISEF · 2017
A Path to Improving Gene Therapies for Liver-Related Diseases and Cancers through Selectable CRISPR-Cas9 Vectors
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects